Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal.

Baranska A, Shawket A, Jouve M, Baratin M, Malosse C, Voluzan O, Vu Manh TP, Fiore F, Bajénoff M, Benaroch P, Dalod M, Malissen M, Henri S, Malissen B.

J Exp Med. 2018 Apr 2;215(4):1115-1133. doi: 10.1084/jem.20171608. Epub 2018 Mar 6.

PMID:
29511065
2.

Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes.

Tkach M, Kowal J, Zucchetti AE, Enserink L, Jouve M, Lankar D, Saitakis M, Martin-Jaular L, Théry C.

EMBO J. 2017 Oct 16;36(20):3012-3028. doi: 10.15252/embj.201696003. Epub 2017 Sep 18.

PMID:
28923825
3.

Blood monocytes sample MelanA/MART1 antigen for long-lasting cross-presentation to CD8+ T cells after differentiation into dendritic cells.

Faure F, Jouve M, Lebhar-Peguillet I, Sadaka C, Sepulveda F, Lantz O, Berre S, Gaudin R, Sánchez-Ramón S, Amigorena S.

Int J Cancer. 2018 Jan 1;142(1):133-144. doi: 10.1002/ijc.31037. Epub 2017 Sep 26.

PMID:
28884480
4.

Mapping the human DC lineage through the integration of high-dimensional techniques.

See P, Dutertre CA, Chen J, Günther P, McGovern N, Irac SE, Gunawan M, Beyer M, Händler K, Duan K, Sumatoh HRB, Ruffin N, Jouve M, Gea-Mallorquí E, Hennekam RCM, Lim T, Yip CC, Wen M, Malleret B, Low I, Shadan NB, Fen CFS, Tay A, Lum J, Zolezzi F, Larbi A, Poidinger M, Chan JKY, Chen Q, Rénia L, Haniffa M, Benaroch P, Schlitzer A, Schultze JL, Newell EW, Ginhoux F.

Science. 2017 Jun 9;356(6342). pii: eaag3009. doi: 10.1126/science.aag3009. Epub 2017 May 4.

PMID:
28473638
5.

Purification of LAT-Containing Membranes from Resting and Activated T Lymphocytes.

Hivroz C, Larghi P, Jouve M, Ardouin L.

Methods Mol Biol. 2017;1584:355-368. doi: 10.1007/978-1-4939-6881-7_21.

PMID:
28255712
6.

The SNARE VAMP7 Regulates Exocytic Trafficking of Interleukin-12 in Dendritic Cells.

Chiaruttini G, Piperno GM, Jouve M, De Nardi F, Larghi P, Peden AA, Baj G, Müller S, Valitutti S, Galli T, Benvenuti F.

Cell Rep. 2016 Mar 22;14(11):2624-36. doi: 10.1016/j.celrep.2016.02.055. Epub 2016 Mar 10.

7.

Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.

Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Théry C.

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77. doi: 10.1073/pnas.1521230113. Epub 2016 Feb 8.

8.

Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens.

Alloatti A, Kotsias F, Pauwels AM, Carpier JM, Jouve M, Timmerman E, Pace L, Vargas P, Maurin M, Gehrmann U, Joannas L, Vivar OI, Lennon-Duménil AM, Savina A, Gevaert K, Beyaert R, Hoffmann E, Amigorena S.

Immunity. 2015 Dec 15;43(6):1087-100. doi: 10.1016/j.immuni.2015.11.006.

9.

[Once upon a time, there was...the nurse in adult psychiatry].

Casotte Y, Chevailler M, Roux C, Jouve M.

Soins Psychiatr. 2014 Nov-Dec;(295):23-5. French.

PMID:
25562912
10.

2D surface temperature measurement of plasma facing components with modulated active pyrometry.

Amiel S, Loarer T, Pocheau C, Roche H, Gauthier E, Aumeunier MH, Le Niliot C, Rigollet F, Courtois X, Jouve M, Balorin C, Moncada V.

Rev Sci Instrum. 2014 Oct;85(10):104905. doi: 10.1063/1.4899210.

PMID:
25362442
11.

Human blood BDCA-1 dendritic cells differentiate into Langerhans-like cells with thymic stromal lymphopoietin and TGF-β.

Martínez-Cingolani C, Grandclaudon M, Jeanmougin M, Jouve M, Zollinger R, Soumelis V.

Blood. 2014 Oct 9;124(15):2411-20. doi: 10.1182/blood-2014-04-568311. Epub 2014 Aug 11.

12.

CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells.

Berre S, Gaudin R, Cunha de Alencar B, Desdouits M, Chabaud M, Naffakh N, Rabaza-Gairi M, Gobert FX, Jouve M, Benaroch P.

J Exp Med. 2013 Nov 18;210(12):2523-38. doi: 10.1084/jem.20130566. Epub 2013 Oct 21.

13.

Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connections.

Gaudin R, Berre S, Cunha de Alencar B, Decalf J, Schindler M, Gobert FX, Jouve M, Benaroch P.

PLoS One. 2013 Jul 29;8(7):e69450. doi: 10.1371/journal.pone.0069450. Print 2013.

14.

A protection system for the JET ITER-like wall based on imaging diagnostics.

Arnoux G, Devaux S, Alves D, Balboa I, Balorin C, Balshaw N, Beldishevski M, Carvalho P, Clever M, Cramp S, de Pablos JL, de la Cal E, Falie D, Garcia-Sanchez P, Felton R, Gervaise V, Goodyear A, Horton A, Jachmich S, Huber A, Jouve M, Kinna D, Kruezi U, Manzanares A, Martin V, McCullen P, Moncada V, Obrejan K, Patel K, Lomas PJ, Neto A, Rimini F, Ruset C, Schweer B, Sergienko G, Sieglin B, Soleto A, Stamp M, Stephen A, Thomas PD, Valcárcel DF, Williams J, Wilson J, Zastrow KD; JET-EFDA Contributors.

Rev Sci Instrum. 2012 Oct;83(10):10D727. doi: 10.1063/1.4738742.

PMID:
23130796
15.

Critical role for the kinesin KIF3A in the HIV life cycle in primary human macrophages.

Gaudin R, de Alencar BC, Jouve M, Bèrre S, Le Bouder E, Schindler M, Varthaman A, Gobert FX, Benaroch P.

J Cell Biol. 2012 Oct 29;199(3):467-79. doi: 10.1083/jcb.201201144. Epub 2012 Oct 22.

16.

Embedded layer of Ag nanoparticles prepared by a combined PECVD/PVD process producing SiOxCy-Ag nanocomposite thin films.

Bedel L, Cayron C, Jouve M, Maury F.

Nanotechnology. 2012 Jan 13;23(1):015603. doi: 10.1088/0957-4484/23/1/015603. Epub 2011 Dec 8.

PMID:
22156142
17.

Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells.

Cebrian I, Visentin G, Blanchard N, Jouve M, Bobard A, Moita C, Enninga J, Moita LF, Amigorena S, Savina A.

Cell. 2011 Dec 9;147(6):1355-68. doi: 10.1016/j.cell.2011.11.021.

18.

New field programmable gate array-based image-oriented acquisition and real-time processing applied to plasma facing component thermal monitoring.

Martin V, Dunand G, Moncada V, Jouve M, Travere JM.

Rev Sci Instrum. 2010 Oct;81(10):10E113. doi: 10.1063/1.3475787.

PMID:
21033978
19.

HIV-1 assembly in macrophages.

Benaroch P, Billard E, Gaudin R, Schindler M, Jouve M.

Retrovirology. 2010 Apr 7;7:29. doi: 10.1186/1742-4690-7-29. Review.

20.

Human immunodeficiency virus type 1 nef expression prevents AP-2-mediated internalization of the major histocompatibility complex class II-associated invariant chain.

Toussaint H, Gobert FX, Schindler M, Banning C, Kozik P, Jouve M, Kirchhoff F, Benaroch P.

J Virol. 2008 Sep;82(17):8373-82. doi: 10.1128/JVI.00670-08. Epub 2008 Jul 2.

21.

HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages.

Jouve M, Sol-Foulon N, Watson S, Schwartz O, Benaroch P.

Cell Host Microbe. 2007 Aug 16;2(2):85-95.

22.

Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age.

Pierga JY, Girre V, Laurence V, Asselain B, Diéras V, Jouve M, Beuzeboc P, Fourquet A, Nos C, Sigal-Zafrani B, Pouillart P; Institut Curie Breast Cancer Study Group.

Breast. 2004 Oct;13(5):369-75.

PMID:
15454191
23.

Breast cancer associated with idiopathic thrombocytopenic purpura: a single center series of 10 cases.

Peffault de Latour R, Des Guetz G, Laurence V, Palangié T, Pierga JY, Diéras V, Jouve M, Extra JM, Pouillart P, Decaudin D.

Am J Clin Oncol. 2004 Aug;27(4):333-6.

PMID:
15289724
24.

Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy.

Vincent-Salomon A, Rousseau A, Jouve M, Beuzeboc P, Sigal-Zafrani B, Fréneaux P, Rosty C, Nos C, Campana F, Klijanienko J, Al Ghuzlan A, Sastre-Garau X; Breast Cancer Study Group.

Eur J Cancer. 2004 Jul;40(10):1502-8.

PMID:
15196533
25.

Wide metastatic spreading in infiltrating lobular carcinoma of the breast.

Ferlicot S, Vincent-Salomon A, Médioni J, Genin P, Rosty C, Sigal-Zafrani B, Fréneaux P, Jouve M, Thiery JP, Sastre-Garau X.

Eur J Cancer. 2004 Feb;40(3):336-41.

PMID:
14746850
26.

Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase.

Stumptner-Cuvelette P, Jouve M, Helft J, Dugast M, Glouzman AS, Jooss K, Raposo G, Benaroch P.

Mol Biol Cell. 2003 Dec;14(12):4857-70. Epub 2003 Sep 17.

27.

Recognition of the cellular beta1-chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa-expressing pathogenic Escherichia coli strains.

Plançon L, Du Merle L, Le Friec S, Gounon P, Jouve M, Guignot J, Servin A, Le Bouguénec C.

Cell Microbiol. 2003 Oct;5(10):681-93.

PMID:
12969374
28.

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response.

Pierga JY, Mouret E, Laurence V, Diéras V, Savigioni A, Beuzeboc P, Dorval T, Palangié T, Jouve M, Pouillart P.

Eur J Cancer. 2003 May;39(8):1089-96.

PMID:
12736108
29.

HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process.

Vincent-Salomon A, Jouve M, Genin P, Fréneaux P, Sigal-Zafrani B, Caly M, Beuzeboc P, Pouillart P, Sastre-Garau X.

Cancer. 2002 Apr 15;94(8):2169-73.

30.

Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates: PCR assays for detection of Afa adhesins that do or do not recognize Dr blood group antigens.

Le Bouguénec C, Lalioui L, du Merle L, Jouve M, Courcoux P, Bouzari S, Selvarangan R, Nowicki BJ, Germani Y, Andremont A, Gounon P, Garcia MI.

J Clin Microbiol. 2001 May;39(5):1738-45.

31.

Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients.

Pierga JY, Robain M, Jouve M, Asselain B, Diéras V, Beuzeboc P, Palangié T, Dorval T, Extra JM, Scholl S, Pouillart P.

Ann Oncol. 2001 Feb;12(2):231-7.

PMID:
11300330
32.

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy.

Pierga JY, Asselain B, Jouve M, Diéras V, Carton M, Laurence V, Girre V, Beuzeboc P, Palangié T, Dorval T, Pouillart P.

Cancer. 2001 Mar 15;91(6):1079-89.

PMID:
11267952
33.

Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer.

Robain M, Pierga JY, Jouve M, Asselain B, Diéras V, Beuzeboc P, Palangié T, Dorval T, Extra JM, Scholl S, Pouillart P.

Eur J Cancer. 2000 Dec;36(18):2301-12.

PMID:
11094303
34.

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.

Pierga JY, Mouret E, Diéras V, Laurence V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Vincent-Salomon A, Scholl S, Extra JM, Asselain B, Pouillart P.

Br J Cancer. 2000 Dec;83(11):1480-7.

35.
36.

Electron microscopic improvement in the study of diarrheagenic Escherichia coli.

Humbert J, Jouve M, Le Bouguénec C, Gounon P.

Microsc Res Tech. 2000 May 15;49(4):383-93. Review.

PMID:
10820522
39.

Prospective cohort study of enterotoxigenic Escherichia coli infections in Argentinean children.

Viboud GI, Jouve MJ, Binsztein N, Vergara M, Rivas M, Quiroga M, Svennerholm AM.

J Clin Microbiol. 1999 Sep;37(9):2829-33.

40.

Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?

Braud AC, Asselain B, Scholl S, De La Rochefordière A, Palangie T, Dieras V, Pierga JY, Dorval T, Jouve M, Beuzeboc P, Pouillart P.

Eur J Cancer. 1999 Mar;35(3):392-7.

PMID:
10448288
41.

Is primary chemotherapy useful for all patients with primary invasive breast cancer?

Scholl SM, Beuzeboc P, Harris AL, Pierga JY, Asselain B, Palangié T, Dorval T, Jouve M, Diéras V, Pouillart P.

Recent Results Cancer Res. 1998;152:217-26. Review.

PMID:
9928560
42.

Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90).

Pierga JY, Jouve M, Asselain B, Livartowski A, Beuzeboc P, Diéras V, Scholl S, Dorval T, Palangié T, Garcia-Giralt E, Pouillart P.

Br J Cancer. 1998 May;77(9):1474-9.

43.

First line protracted venous infusion fluorouracil with CisDDP or carboplatine in advanced colorectal cancer.

Garcia-Giralt E, Omodei Zorini C, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P.

Clin Ter. 1997 Sep;148(9):393-401. No abstract available.

PMID:
9374077
44.
45.

Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.

Pierga JY, Diéras V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Scholl SM, Garcia-Giralt E, Pouillart P.

Gynecol Oncol. 1997 Aug;66(2):246-9.

PMID:
9264570
46.

Phase II trial of decapeptyl (D-TRP-6), a potent luteinizing hormone-releasing hormone analogue in untreated advanced breast cancer.

Garcia-Giralt E, Beuzeboc P, Dieras V, Dorval T, Jouve M, Livartowski A, Palangie T, Scholl S, Pouillart P.

Am J Clin Oncol. 1996 Oct;19(5):455-8.

PMID:
8823473
47.

[Comparison of the double burst stimulus with the train-of-four stimuli in monitoring muscle relaxation during anesthesia].

González-Arévalo A, Pensado A, Caro MM, Jiménez J, Jouve MJ.

Rev Esp Anestesiol Reanim. 1996 Aug-Sep;43(7):235-8. Spanish.

PMID:
8966350
48.

First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.

Garcia-Giralt E, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P.

J Infus Chemother. 1996 Summer;6(3):149-51.

PMID:
9229328
49.

Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.

Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, Beuzeboc P, Dorval T, Pouillart P.

Cancer. 1996 Apr 1;77(7):1315-23.

PMID:
8608509
50.

Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancer.

Dorval T, Soussain C, Beuzeboc P, Garcia-Giralt E, Jouve M, Livartowski A, Mosseri V, Palangié T, Scholl S, Sastre X, Pouillart P.

J Infus Chemother. 1996 Winter;6(1):47-9.

PMID:
8748008

Supplemental Content

Support Center